GNLX
Price
$2.40
Change
-$0.08 (-3.23%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
93.58M
SNSE
Price
$0.34
Change
-$0.02 (-5.56%)
Updated
May 14, 04:48 PM (EDT)
Capitalization
8.57M
78 days until earnings call
Ad is loading...

GNLX vs SNSE

Header iconGNLX vs SNSE Comparison
Open Charts GNLX vs SNSEBanner chart's image
Genelux
Price$2.40
Change-$0.08 (-3.23%)
Volume$2.73K
Capitalization93.58M
Sensei Biotherapeutics
Price$0.34
Change-$0.02 (-5.56%)
Volume$130
Capitalization8.57M
GNLX vs SNSE Comparison Chart
Loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNLX vs. SNSE commentary
May 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a Hold and SNSE is a Hold.

Ad is loading...
COMPARISON
Comparison
May 15, 2025
Stock price -- (GNLX: $2.48 vs. SNSE: $0.36)
Brand notoriety: GNLX and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 195% vs. SNSE: 6%
Market capitalization -- GNLX: $93.58M vs. SNSE: $8.57M
GNLX [@Biotechnology] is valued at $93.58M. SNSE’s [@Biotechnology] market capitalization is $8.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $289.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, SNSE is a better buy in the long-term than GNLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 4 TA indicator(s) are bullish while SNSE’s TA Score has 2 bullish TA indicator(s).

  • GNLX’s TA Score: 4 bullish, 4 bearish.
  • SNSE’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, GNLX is a better buy in the short-term than SNSE.

Price Growth

GNLX (@Biotechnology) experienced а +6.44% price change this week, while SNSE (@Biotechnology) price change was -10.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.93%. For the same industry, the average monthly price growth was +6.80%, and the average quarterly price growth was -5.97%.

Reported Earning Dates

GNLX is expected to report earnings on May 07, 2025.

SNSE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+0.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNLX($93.6M) has a higher market cap than SNSE($8.57M). GNLX YTD gains are higher at: 5.085 vs. SNSE (-27.280). SNSE (-28.38M) and GNLX (-28.78M) have comparable annual earnings (EBITDA) . SNSE has more cash in the bank: 47M vs. GNLX (35.1M). GNLX has less debt than SNSE: GNLX (1.79M) vs SNSE (4.47M). GNLX (0) and SNSE (0) have equivalent revenues.
GNLXSNSEGNLX / SNSE
Capitalization93.6M8.57M1,092%
EBITDA-28.78M-28.38M101%
Gain YTD5.085-27.280-19%
P/E RatioN/AN/A-
Revenue00-
Total Cash35.1M47M75%
Total Debt1.79M4.47M40%
TECHNICAL ANALYSIS
Technical Analysis
GNLXSNSE
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
89%
Bullish Trend 20 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGIC15.200.77
+5.34%
Magic Software Enterprises Ltd
ADNT15.900.29
+1.86%
Adient plc
INTT6.090.10
+1.67%
inTEST Corp
NURO4.58N/A
N/A
NeuroMetrix
GGG85.74-0.70
-0.81%
Graco

GNLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
-10.79%
VSTM - GNLX
47%
Loosely correlated
+2.33%
SNSE - GNLX
30%
Poorly correlated
-1.76%
ANIX - GNLX
27%
Poorly correlated
+0.38%
ZLDAF - GNLX
26%
Poorly correlated
N/A
BHVN - GNLX
26%
Poorly correlated
-5.11%
More

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
-1.76%
VSTM - SNSE
46%
Loosely correlated
+2.33%
GRI - SNSE
40%
Loosely correlated
-3.87%
ALZN - SNSE
40%
Loosely correlated
-18.83%
FATE - SNSE
36%
Loosely correlated
-6.54%
INAB - SNSE
33%
Loosely correlated
-1.84%
More